RxDoctor Payments Data

Kent Kronowski, DPM

Primary Podiatric Medicine · Augusta, GANPI 1881745842

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations.

$947in general payments, 2019–2025

Across 40 payments — averaging $23.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$152
  • ANI Pharmaceuticals, Inc.$106
  • Convatec Inc.$97
  • Melinta Therapeutics, LLC$84
  • Organogenesis Inc.$74
  • Smith+Nephew$68
  • plus $366 from 11 others

What the payments were for

  • Food & beverage$947100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few primary podiatric medicine providers in Georgiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$189,693
Medicare patients
752
Services billed
3,969

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole201$6,786
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip42$1,252
Colchicine23$898
Mupirocin97$856
Ammonium Lactate50$743
Clotrimazole12$480
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav20$290
Triamcinolone Acetonide25$283
Gabapentin44$229
Doxycycline Hyclate25$208
Cephalexin12$73
Meloxicam13$42

Paid to pharmacies, not to this prescriber.

Other primary podiatric medicine in Augusta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →